liraglutide - Victoza; Arg34-GLP-1[7-37]; GLP-1 [recombinant]; NN-2211 -- Product Record

Glucagon-like peptide-1, rDNA

    Nomenclature:
      Liraglutide [USAN; INN]
      Liraglutide (genetical recombination) [JAN]
      Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl- [CAS]
      N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide; Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-l [CAS]
      204656-20-2 [CAS RN]
      Arg34-GLP-1[7-37] [SY]
      Arg34-GLP-1[7-37] [SY]
      Arg34Lys26-(N-є-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37] [SY]
      D06404 [SY]
      N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide [SY]
      N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide [SY]
      NN 2211 [SY]
      NN2211 [SY]
      NNC 90-1170 [SY]
      NDC 0169-4060-12 [NDC]
      NDC 0169-4060-13 [NDC]

    molecular weight (kDa) = 3.75

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 2010